Cargando…
P23. Efficient ex vivo lysis of acute myeloid leukaemic (AML) cells mediated by triplebodies with dual-targeting capability in conjunction with natural killer cells as effectors
Autores principales: | Fey, G, Braciak, TA, Wildenhain, S, Roskopf, CC, Schiller, C, Fenn, N, Schubert, IA, Jacob, U, Hopfner, KP, Oduncu, FS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071944/ http://dx.doi.org/10.1186/2051-1426-2-S2-P14 |
Ejemplares similares
-
P28. Efficient CD19-positive leukaemia cell lysis mediated by a T cell-recruiting triple body a[19-3-19]
por: Roskopf, CC, et al.
Publicado: (2014) -
Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19(+) CD33(+) leukemia cells
por: Roskopf, Claudia C., et al.
Publicado: (2016) -
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell
por: Roskopf, Claudia C., et al.
Publicado: (2014) -
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2
por: Braciak, Todd A, et al.
Publicado: (2013) -
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells
por: Braciak, Todd A., et al.
Publicado: (2018)